Clinical Trial Update: Phase II Clinical Trial to Evaluate the Efficacy and Safety of NV01-A02 in Children With Autism Spectrum Disorder [Phase 2]

View source ↗

Summary

A Phase II clinical trial is evaluating the efficacy and safety of NV01-A02 in children with autism spectrum disorder, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• NV01-A02

Snippet

Sponsor: Neuroventi Inc. | Conditions: Autism Spectrum Disorder (ASD | Phase 2 | Status: RECRUITING